Yasunori Aoki

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 13

Top Topics

Human Serum Albumin

Pulmonary Arterial Hypertension

Top Venues

CPT: pharmacometrics & systems pharmacology

Drug metabolism and disposition: the biological fate of chemicals

This page only lists publications with an associated author ORCID identifier.

Publications

Toshiaki Tsuchitani, Atsuko Tomaru, Yasunori Aoki, Naoki Ishiguro, Yasuhiro Tsuda, Yuichi Sugiyama
Elucidating nonlinear pharmacokinetics of telmisartan: Integration of target-mediated drug disposition and OATP1B3-mediated hepatic uptake in a physiologically based model. CPT: pharmacometrics & systems pharmacology 13 (7) (2024)
Toshiaki Tsuchitani, Atsuko Tomaru, Yasunori Aoki, Naoki Ishiguro, Yasuhiro Tsuda, Yuichi Sugiyama
Elucidating nonlinear pharmacokinetics of telmisartan: Integration of target-mediated drug disposition and OATP1B3-mediated hepatic uptake in a physiologically based model. CPT: pharmacometrics & systems pharmacology (2024)
Toshiaki Tsuchitani, Atsuko Tomaru, Yasunori Aoki, Naoki Ishiguro, Yasuhiro Tsuda, Yuichi Sugiyama
Elucidating nonlinear pharmacokinetics of telmisartan: Integration of target-mediated drug disposition and OATP1B3-mediated hepatic uptake in a physiologically based model. CPT: pharmacometrics & systems pharmacology 13 (7) (2024)
Toshiaki Tsuchitani, Atsuko Tomaru, Yasunori Aoki, Naoki Ishiguro, Yasuhiro Tsuda, Yuichi Sugiyama
Elucidating nonlinear pharmacokinetics of telmisartan: Integration of target-mediated drug disposition and OATP1B3-mediated hepatic uptake in a physiologically based model. CPT: pharmacometrics & systems pharmacology 13 (7) (2024)
Toshiaki Tsuchitani, Atsuko Tomaru, Yasunori Aoki, Naoki Ishiguro, Yasuhiro Tsuda, Yuichi Sugiyama
Elucidating nonlinear pharmacokinetics of telmisartan: Integration of target-mediated drug disposition and OATP1B3-mediated hepatic uptake in a physiologically based model. CPT: pharmacometrics & systems pharmacology 13 (7) (2024)
Yuichi Sugiyama, Yasunori Aoki
A 20-Year Research Overview: Quantitative Prediction of Hepatic Clearance Using the IVIVE Approach Based on PBPK Modeling and Extended Clearance Concept. Drug metabolism and disposition: the biological fate of chemicals (2023)
Yasunori Aoki, Yuichi Sugiyama
Cluster Gauss-Newton method for a quick approximation of profile likelihood: With application to physiologically-based pharmacokinetic models. CPT: pharmacometrics & systems pharmacology (2023)
Yasunori Aoki, Claudia S Cabrera, Mario Ouwens, Krister Bamberg, Jenny Nyström, Itamar Raz, Benjamin M Scirica, Bengt Hamrén, Peter J Greasley, Dinko Rekić
Bilirubin levels and kidney function decline: An analysis of clinical trial and real world data. PloS one 17 (6) (2022)
Lovisa Sandberg, Henric Taavola, Yasunori Aoki, Rebecca E Chandler, G Niklas Norén
Risk Factor Considerations in Statistical Signal Detection: Using Subgroup Disproportionality to Uncover Risk Groups for Adverse Drug Reactions in VigiBase. Drug safety 43 (10) (2021)
Rika Wakao, Ingrid M Lönnstedt, Yasunori Aoki, Rebecca E Chandler
The Use of Subgroup Disproportionality Analyses to Explore the Sensitivity of a Global Database of Individual Case Safety Reports to Known Pharmacogenomic Risk Variants Common in Japan. Drug safety 44 (6) (2021)
Yasunori Aoki, Bengt Hamrén, Lindsay E Clegg, Christina Stahre, Deepak L Bhatt, Itamar Raz, Benjamin M Scirica, Jan Oscarsson, Björn Carlsson
Assessing reproducibility and utility of clustering of patients with type 2 diabetes and established CV disease (SAVOR -TIMI 53 trial). PloS one 16 (11) (2021)
Ola Caster, Yasunori Aoki, Lucie M Gattepaille, Birgitta Grundmark
Disproportionality Analysis for Pharmacovigilance Signal Detection in Small Databases or Subsets: Recommendations for Limiting False-Positive Associations. Drug safety 43 (5) (2021)
Yasunori Aoki, Daniel Röshammar, Bengt Hamrén, Andrew C Hooker
Model selection and averaging of nonlinear mixed-effect models for robust phase III dose selection. Journal of pharmacokinetics and pharmacodynamics 44 (6) (2017)